Suchergebnisse - "Transthyretin amyloid cardiomyopathy"

PubPharm (172)

1

Prevalence of transthyretin amyloid cardiomyopathy in pacemaker patients

enthalten in: ESC heart failure | 2024

von Aaseth, E. | Christiansen, J.

2

Efficacy of Computed Tomography-Based Evaluation of Myocardial Extracellular Volume Combined With Red Flags for Early Screening of Concealed Cardiac Amyloidosis in Patients With Atrial Fibrillation

enthalten in: Circulation journal : official journal of the Japanese Circulation Society | 2024

von Yamasaki, H. | Kondo, H. | Shiroo, T. | +31

3

Effect of long-term tafamidis treatment on health-related quality of life in patients with transthyretin amyloid cardiomyopathy

enthalten in: European journal of heart failure | 2024

von Grogan, M. | Davis, M. | Crespo-Leiro, M. | +4

4

Biochemical and biophysical properties of a rare TTRA81V mutation causing mild transthyretin amyloid cardiomyopathy

enthalten in: ESC heart failure | 2024

von Sha, Q. | Zhang, Y. | Wang, M. | +6

5

Extending the reach of expert amyloidosis care : A feasibility study exploring the staged implementation of a UK amyloidosis network

enthalten in: Clinical medicine (London, England) | 2024

von Choy, C. | Steeds, R. | Pinney, J. | +15

6

Multiparametric Monitoring of Disease Progression in Contemporary Patients with Wild-Type Transthyretin Amyloid Cardiomyopathy Initiating Tafamidis Treatment

enthalten in: Journal of clinical medicine | 2024

von Ney, S. | Gertz, R. | Pennig, L. | +12

7

Biochemical and biophysical properties of a rare TTRA81V mutation causing mild transthyretin amyloid cardiomyopathy

in: ESC Heart Failure | 2024

von Qiuyan Sha | Yanli Zhang | Mengdie Wang | +6

8

Multiparametric Monitoring of Disease Progression in Contemporary Patients with Wild-Type Transthyretin Amyloid Cardiomyopathy Initiating Tafamidis Treatment

in: Journal of Clinical Medicine | 2024

von Svenja Ney | Roman Johannes Gertz | Lenhard Pennig | +12

9

Prevalence of transthyretin amyloid cardiomyopathy in pacemaker patients

in: ESC Heart Failure | 2024

von Eirik Aaseth | Jon R. Christiansen

10

Cost-effectiveness of systematic screening and treatment of transthyretin amyloid cardiomyopathy (ATTR-CM) in patients with heart failure with preserved ejection fraction (HFpEF) in United States

enthalten in: International journal of cardiology | 2024

von Lau, A. | DiDomenico, R. | Kim, K.

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[18]